Risk factors for recurrent heart failure events in the multicenter automatic defibrillator implantation trial II (MADIT-II)

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 11, 2010, Pages 1217-1223

  Sze, Edward ^a   Moss, Arthur J ^a   McNitt, Scott ^a   Barsheshet, Alon ^a   Andrews, Mark L ^a   Zareba, Wojciech ^a   Goldenberg, Ilan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Ischemic cardiomyopathy; Renal dysfunction; Sudden death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL; UREA NITROGEN BLOOD LEVEL; UREMIA;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MINNESOTA; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 78249253631     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01789.x     Document Type: Article

References (28)

1. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 2008; 117: e350 -e408.
2. Goldenberg I, Moss AJ,: Implantable cardioverter defibrillator efficacy and chronic kidney disease: Competing risks of arrhythmic and nonarrhythmic mortality. J Cardiovasc Electrophysiol 2008; 19: 1281 -1283.
3. Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA,: Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: A VALIANT study. Eur Heart J 2008; 29: 748 -756.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,; Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877 -883.
5. Morgan DB, Carver ME, Payne RB,: Plasma creatinine and urea: Creatinine ratio in patients with raised plasma urea. BMJ 1977; 2: 929 -932.
6. J.B. Dossetor,: Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med 1966; 65: 1287 -1299
7. Lin HJ, Chao CL, Chien KL, Ho YL, Lee CM, Lin YH, Wu YW, Hsu RB, Chou NK, Wang SS, Chen CY, Chen MF,: Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure. Clin Res Cardiol 2009; 98: 487 -492.
8. National Kidney Foundation. Kidney Disease Outcome Quality Initiative (K/DOQI): Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1 -S266.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rodgers N, Roth D,: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461 -470.
10. Prentice RL, Williams BJ, Peterson AV,: On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373 -379.
11. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S,: A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004; 116: 300 -304. (Pubitemid 38230288)
12. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M,: The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424 -1433.
13. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW,: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with LV systolic dysfunction. J Am Coll Cardiol 2000; 35: 681 -689.
14. Hillege HL, Girbes AR, De Kam PJ, Boomsma F, De Zeeuw D, Charlesworth A, Hampton JR, Van Veldhuisen DJ,: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203 -210.
15. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ,: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955 -962.
16. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, De Zeeuw D, Pocock S, Van Veldhuisen DJ,; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671 -678.
17. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA,: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285 -1295.
18. Schrier R,: Role of diminished renal function in cardiovascular mortality: Marker or pathogenic factor. J Am Coll Cardiol 2006; 47: 1 -8.
19. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, Case RB,; Multicenter Automatic Defibrillator Implantation Trial-II Investigators: Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006; 98: 485 -490.
20. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH,: Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006; 17: 940 -943.
21. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, White C, Saklayen M, McCullough PA,: Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004; 11: 199 -204.
22. Amin MS, Fox AD, Kalahasty G, Shephard RK, Wood MA, Ellenbogen KA,: Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol 2008; 19: 1275 -1280.
23. Hirsch At, Pinto YM, Schunkert H, Dzau VJ,: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 1990; 66: 22D -30D.
24. Goldenberg I, Moss AJ, W, Hall J, McNitt S, Zareba W, Andrews ML, Cannom DS, Klein HU,; for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006; 113: 2810 -2817.
25. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH,: Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1058 -1059.
26. Schrier RW, Gurevich A, Abraham W,: Renal sodium excretion, edematous disorders, and diuretic use. In:, Schrier RW, ed. Renal and Electrolyte Disorders, 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2002, pp. 64 -114.
27. Dharnidharka VR, Kwon C, Stevens G,: Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002; 40: 221 -226.
28. Thadhani R, Pascual M, Bonventre JV,: Acute renal failure. N Engl J Med 1996; 334: 1448 -1460.